Zhonghong Pulin Medical Products Co., Ltd. (SHE:300981)
China · Delayed Price · Currency is CNY 20.30
+2.40 (13.41%)
Sep 30, 2026, 3:04 PM CST
SHE:300981 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 8,677 | 5,369 | 4,997 | 6,248 | 5,634 | 13,324 | |
Market Cap Growth | 51.83% | 7.43% | -20.02% | 10.90% | -57.71% | - |
Enterprise Value | 6,616 | 4,393 | 3,332 | 4,248 | 1,896 | 9,471 |
Last Close Price | 20.30 | 12.25 | 11.18 | 13.26 | 11.59 | 25.76 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 216.27 | - | - | - | 84.20 | 5.69 |
Forward PE | - | 25.63 | 34.29 | - | - | - |
PS Ratio | 3.32 | 2.26 | 2.03 | 2.97 | 3.58 | 2.71 |
PB Ratio | 1.60 | 0.99 | 0.89 | 1.06 | 0.92 | 2.03 |
P/TBV Ratio | 1.73 | 1.07 | 0.97 | 1.18 | 0.94 | 2.05 |
P/FCF Ratio | 173.15 | - | 65.31 | - | - | 9.63 |
P/OCF Ratio | 35.13 | 1437.09 | 27.17 | 149.80 | 52.80 | 5.64 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.53 | 1.85 | 1.36 | 2.02 | 1.21 | 1.93 |
EV/EBITDA Ratio | 20.55 | 46.33 | 19.02 | 165.55 | - | 3.42 |
EV/EBIT Ratio | 61.55 | - | - | - | - | 3.52 |
EV/FCF Ratio | 132.02 | - | 43.56 | - | - | 6.84 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.29 | 0.26 | 0.16 | 0.09 | 0.01 | 0.00 |
Debt / EBITDA Ratio | 4.91 | 13.71 | 4.84 | 15.57 | 29.51 | 0.01 |
Debt / FCF Ratio | 31.55 | - | 11.49 | - | - | 0.01 |
Net Debt / Equity Ratio | -0.41 | -0.40 | -0.43 | -0.41 | -0.58 | -0.67 |
Net Debt / EBITDA Ratio | -7.05 | -22.99 | -13.73 | -94.75 | 2119.96 | -1.58 |
Net Debt / FCF Ratio | -44.33 | 11.66 | -31.45 | 39.55 | 35.53 | -3.17 |
Asset Turnover | 0.34 | 0.32 | 0.34 | 0.30 | 0.23 | 0.91 |
Inventory Turnover | 3.36 | 3.59 | 4.04 | 4.33 | 3.51 | 5.18 |
Quick Ratio | 2.10 | 2.28 | 3.03 | 4.33 | 6.14 | 8.27 |
Current Ratio | 2.53 | 2.68 | 3.70 | 5.19 | 6.91 | 9.21 |
Return on Equity (ROE) | 0.69% | -2.11% | -1.49% | -2.12% | 1.06% | 51.41% |
Return on Assets (ROA) | 0.88% | -1.03% | -0.33% | -1.57% | -1.30% | 31.10% |
Return on Invested Capital (ROIC) | 2.47% | -3.72% | -1.13% | -5.78% | -6.19% | 148.85% |
Return on Capital Employed (ROCE) | 1.90% | -2.10% | -0.60% | -2.80% | -2.40% | 40.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 0.47% | -2.09% | -1.74% | -2.10% | 1.19% | 17.58% |
FCF Yield | 0.58% | -3.48% | 1.53% | -0.98% | -1.79% | 10.39% |
Dividend Yield | 1.72% | 2.86% | 2.24% | 3.43% | 4.22% | 6.79% |
Payout Ratio | 455.88% | - | - | - | 749.13% | 10.76% |
Buyback Yield / Dilution | 0.98% | 0.78% | -2.89% | 2.24% | -10.19% | -22.18% |
Total Shareholder Return | 2.71% | 3.64% | -0.66% | 5.67% | -5.96% | -15.39% |